1. European Commission. A cancer plan for Europe. Feb 2021. https://ec.europa.eu/info/strategy/priorities-2019-2024/promoting-our-european-way-life/european-health-union/cancer-plan-europe_en. Accessed Nov 2021.
2. Wouters OJ, McKee M, Luyten J. Estimated research and development investment needed to bring a new medicine to market, 2009–2018. JAMA. 2020;323(9):844–53.
3. Krendyukov A, Gattu S. Critical factors shaping strategy development of an innovative medicine in oncology. Pharm Med. 2020;34(2):103–12.
4. US Food and Drug Administration. The drug development process. https://www.fda.gov/ForPatients/Approvals/Drugs/default.htm. Accessed 1 Mar 2022.
5. European Medicines Agency. The European regulatory system for medicines: a consistent approach to medicines regulation across the European Union, 2017. https://www.ema.europa.eu/en/documents/leaflet/european-regulatory-system-medicines-european-medicines-agency-consistent-approach-medicines_en.pdf. Accessed 11 Feb 2022.